nivolumab
Drug Name | Form | Strength | ARHS | Blue Ridge | Caldwell | Chatham | Johnston | Lenoir | Medical Center | Nash | Pardee | Rex | Rockingham | Southeastern | Wayne | Youth Behavioral Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nivolumab (Opdivo) | SOLUTION, INTRAVENOUS | 10 mg/mL (10 mL) | ||||||||||||||
Nivolumab (Opdivo) | SOLUTION, INTRAVENOUS | 10 mg/mL (24 mL) | ||||||||||||||
Nivolumab (Opdivo) | SOLUTION, INTRAVENOUS | 10 mg/mL (4 mL) | ||||||||||||||
Nivolumab-Hyaluronidase-nvhy (Opdivo Qvantig) | SOLUTION, SUBCUTANEOUS | 600 mg-10,000 units/5 mL |
UNC Health
System Formulary Restriction:
Use of nivolumab injection is restricted to outpatient encounters or clinic use only (ie, no inpatient use)
Med Center
UNC Medical Center Formulary Restrictions
Rex
Rex Hematology-Oncology Formulary Restrictions